Turn Therapeutics Stock (NASDAQ:TTRX)


OwnershipFinancialsChart

Previous Close

$9.58

52W Range

$2.57 - $26.50

50D Avg

$6.10

200D Avg

$4.50

Market Cap

$268.99M

Avg Vol (3M)

$66.13K

Beta

2.10

Div Yield

-

TTRX Company Profile


Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Oct 08, 2025

Website

TTRX Performance


TTRX Financial Summary


Dec 24Dec 23
Revenue--
Operating Income$-1.80M$-2.31M
Net Income$-1.77M$-2.29M
EBITDA$-1.75M$-2.26M
Basic EPS--
Diluted EPS--

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison


TickerCompany
IRDOpus Genetics, Inc.
IKTInhibikase Therapeutics, Inc.
ANIXAnixa Biosciences, Inc.
GLSIGreenwich LifeSciences, Inc.
TVGNTevogen Bio Holdings Inc.
AGENAgenus Inc.
SEERSeer, Inc.
HURATuHURA Biosciences, Inc.
VTGNVistaGen Therapeutics, Inc.
CGTXCognition Therapeutics, Inc.